Success Metrics

Clinical Success Rate
100.0%

Based on 14 completed trials

Completion Rate
100%(14/14)
Active Trials
1(6%)
Results Posted
14%(2 trials)

Phase Distribution

Ph phase_3
2
12%
Ph not_applicable
6
35%
Ph phase_2
3
18%
Ph phase_1
6
35%

Phase Distribution

6

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
6(35.3%)
Phase 2Efficacy & side effects
3(17.6%)
Phase 3Large-scale testing
2(11.8%)
N/ANon-phased studies
6(35.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

93.3%

14 of 15 finished

Non-Completion Rate

6.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

17

all time

Status Distribution
Active(1)
Completed(14)
Terminated(1)
Other(1)

Detailed Status

Completed14
Withdrawn1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (35.3%)
Phase 23 (17.6%)
Phase 32 (11.8%)
N/A6 (35.3%)

Trials by Status

withdrawn16%
active_not_recruiting16%
unknown16%
completed1482%

Recent Activity

1 active trials
Showing 5 of 17
completedphase_1

A Dose Response Investigation of Docosahexaenoic Acid (DHA)

NCT06294067
active_not_recruitingphase_2

Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting

NCT03831178
completednot_applicable

Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma

NCT05527106
completedphase_1

Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates

NCT01745510
completedphase_1

DHA For The Treatment of Pediatric Concussion Related to Sports Injury

NCT01903525
View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06294067Phase 1

A Dose Response Investigation of Docosahexaenoic Acid (DHA)

Completed
NCT03831178Phase 2

Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting

Active Not Recruiting
NCT05527106Not Applicable

Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma

Completed
NCT01745510Phase 1

Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates

Completed
NCT01903525Phase 1

DHA For The Treatment of Pediatric Concussion Related to Sports Injury

Completed
NCT03582267Not Applicable

The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

Completed
NCT01563913Phase 1

Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids

Completed
NCT00530244Not Applicable

Use of Formula Fortified With DHA in Infants With Cystic Fibrosis

Completed
NCT00014027Phase 1

Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress

Completed
NCT01580345Phase 3

Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India.

Completed
NCT01051154Phase 2

Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic Leukemia

Completed
NCT02336243Phase 3

A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders

Unknown
NCT00577447Not Applicable

Docosahexaenoic Acid in the Treatment of Autism

Completed
NCT00325013Phase 1

Evaluation of DHA for the Treatment of PSC

Completed
NCT00691418Not Applicable

Docosahexaenoic Acid (DHA) Administration and Length of Gestation: a Feasibility Study

Withdrawn
NCT00749307Phase 2

Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients

Completed
NCT00610922Not Applicable

Docosaexahenoic Acid and Gross Motor Milestones in Infants

Completed

All 17 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
17